TEI-3356

N/A

Report date: 2024/01/25 09:17:39

Base Information

Drug NameTEI-3356

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstanoid EP3 receptor agonists

TargetsProstanoid EP3 receptor

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTeijin Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTeijin Pharma

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A